Evidence map›Paper›PMID 18036805›Full record

ReviewCurrent opinion in immunology2007

Microarray-based identification of novel biomarkers in IL-1-mediated diseases.

Florence Allantaz, Damien Chaussabel, Jacques Banchereau, Virginia Pascual

Abstract readReview
In one paragraph

Review in Current opinion in immunology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Florence AllantazBaylor Institute for Immunology Research and Baylor Research Institute, Dallas, TX, USA.
Damien Chaussabel
Jacques Banchereau
Virginia Pascual

Funding

Targeting Dendritic Cells for Enhanced Musocal ImmunityU19AI057234 · NIAID · BAYLOR RESEARCH INSTITUTE · PI PALUCKA, ANNA KAROLINA · 2003 to 2013
$49.2M
Use of Microarrays to Understand Systemic ArthritisR01AR050770 · NIAMS · BAYLOR RESEARCH INSTITUTE · PI PASCUAL, MARIA VIRGINIA · 2003 to 2012
$3.1M
SUBPOPULATIONS OF HUMAN DENDRITIC CELLSR01CA078846 · NCI · BAYLOR RESEARCH INSTITUTE · PI BANCHEREAU, JACQUES F · 1999 to 2008
$2.5M
NCI NIH HHS CA78846NCI NIH HHS R01 CA078846NIAID NIH HHS U19 AI057234-02NIAMS NIH HHS R01 AR050770NIAMS NIH HHS R01 AR050770-01
6 · The paper itself

Abstract

Interleukin 1b (IL-1b) is emerging as mediator of a wide range of human diseases. Availability of IL-1 blockers that result in clinical benefits to patients with these diseases is creating a demand for biomarkers to diagnose as well as to predict and follow responses to therapy. Blood gene expression profiling can be used to identify such biomarkers. This review will summarize recent studies in the field and will discuss some of the challenges raised by the use of this technology in biomarker discovery.

Indexed as

Gene Expression ProfilingArthritis, JuvenileBiomarkersDiabetes MellitusHumansImmune System DiseasesInflammationInterleukin-1Microarray AnalysisOligonucleotide Array Sequence AnalysisReceptors, Interleukin-1BiomarkersInterleukin-1Receptors, Interleukin-1

Identifiers

PMID18036805
PMCPMC2747489

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.